Physician profile
Preachess Vellah
NPI 1629069182
$3,425.65
in general payments reported to CMS, 2019-2025
16 companies · $932 in 2025
The $932 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $944 · 2020: $191 · 2021: $428 · 2022: $423 · 2023: $135 · 2024: $373 · 2025: $932.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $623.01 | 2019-2025 | Wegovy, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $523.24 | 2020-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $319.12 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $250.80 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $242.83 | 2025 | Airsupra |
| Vifor Pharma, INC. | $240.00 | 2021 | |
| Boston Scientific Corporation | $190.08 | 2022-2025 | Spyglass Discover |
| Pfizer INC. | $187.94 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $135.00 | 2023 | Camzyos |
| Abbott Laboratories | $124.35 | 2019 | |
| Lilly USA, LLC | $124.11 | 2025 | Kisunla |
| Philips North America LLC | $112.47 | 2022 | |
| Medtronic, INC. | $99.53 | 2025 | Closurefast |
| Abbvie INC. | $98.00 | 2021 | |
| Amgen INC. | $96.38 | 2024 | Krystexxa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $58.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preachess Vellah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.